WHO Tackles Submission Of Insufficient Or False Data By Pharma
This article was originally published in The Gold Sheet
The World Health Organization has issued guidance on data integrity that provides a comprehensive, global perspective on the issue.
You may also be interested in...
Data integrity spotlight expands beyond cGMP as FDA finds Semler manipulated study subject samples in bioequivalence studies conducted at its Bangalore facility.
The (virtual) doors closing on the J.P. Morgan Healthcare Conference is the sign for the biopharma industry that the new year has truly started, but before we get too far into 2021, Scrip has taken a look at five of the biggest non-COVID-19 story themes of 2020 in no particular order.
Our graphic tracker of key developments from emergency authorized vaccines, the global roll-out, and late-stage vaccine candidates.